期刊文献+

特发性矮小患儿血中p53及p21waf/cip1的表达 被引量:3

Expressions of p53 and p21 waf/cip1 in blood of children with idiopathic short stature
下载PDF
导出
摘要 目的:观察特发性矮小(ISS)患儿血中p53及细胞周期调节基因p21waf/cip1的表达,探讨二者与ISS发病机制之间的关系。方法:采用实时荧光定量PCR及ELISA法检测30例ISS患儿(ISS组)和30名正常儿童(对照组)外周血中p53和p21waf/cip1 mRNA的表达水平及血清中P53和P21waf/cip1蛋白的含量。结果:ISS组患儿外周血中p53 mRNA的表达水平及血清P53的浓度与对照组相比,差异无统计学意义(t=1.044和0.701,P均>0.05),ISS组p21waf/cip1 mRNA的表达水平较对照组升高(t=4.606,P<0.001)。结论:p21waf/cip1可能通过非依赖p53途径参与ISS的发生。 Aim : To investigate the expressions of p53 and p21waf/cipl in blood of children with idiopathic short stature(ISS) and to elucidate the pathogenesis of ISS. Methods: Real-time PCR was used to measure the expressions of p53 mRNA and p2lwaf/cipl mRNA in peripheral blood from 30 children with ISS(JSS group) and 30 normal control{control group) ; ELISA was used to measure the levels of P53 and P21waf/cipl in serum of the children in the 2 groups. Results: The expression of p53 mRNA and the concentration of serum P53 had no statistical significance between the 2 groups( t = 1. 044 and 0. 701,P 〉 0.05). The expression of p21waf/cipl mRNA in ISS group was significantly higher than those in the control group( t = 4. 066 ,P 〈 0. 001 ). Conclusion : p21waf/cipl may be responsible for the pathogenesis of ISS, which might not depends on p53 pathway.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2015年第2期191-193,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省医学科技攻关计划项目201303092 河南省卫生科技创新型人才工程专项经费资助豫卫科201052
关键词 P53 p21waf/cip1 特发性矮小 儿童 p53 p21waf/cip1 idiopathic short stature children
  • 相关文献

参考文献3

二级参考文献33

  • 1Clapper J,Taylor A. Components of the porcine anterior pituitary insu- lin -like growth factor system throughout the estrous cycle[ J]. Domest Anim Endocrinol,2011,40 ( 2 ) :67 - 76.
  • 2Duan C, Ren H,Gao S. Insulin - like growth factors ( IGFs), IGF re- ceptors,and IGF -binding proteins: Roles in skeletal muscle growth and differentiation [ J ]. Gen Comp Endocrinol, 2010,167 ( 3 ) : 344 - 351.
  • 3Fang P, Schwartz ID, Johnson BD, et al. Familial short stature caused by haploinsufficiency of the insulin - like growth factor I receptor due to nonsense - mediated messenger ribonucleic acid decay [ J ]. J Clin Endocrinol Metab, 2009,94 ( 5 ) : 1740 - 1747.
  • 4Wit JM, Kiess W, Mullis P. Genetic evaluation of short stature[ J ]. Best Pract Res Clin Endocrinol Metab, 2011,25 ( 1 ) :1 - 17.
  • 5Cohen P, Rogol AD, Deal CL,et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature : A summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endo- crine Society, and the European Society for Paediatric Endocrinology Workshop[ J]. J Clin Endocrinol Metab ,2008,93 ( 11 ) :4210 - 4217.
  • 6Savage MO,Burren CP,Rosenfcld RG. The continuum of growth hog,none - IGF- I axis defects causing short stature: Diagnostic and therapeutic challenges [ J ]. Clin Endocrinol, 2009,72 ( 6 ) : 721 - 728.
  • 7Ziv E, Hu D. Genetic variation in insulin/IGF - 1 signaling pathways and longevity [ J ]. Ageing Res Rev,2011,10 ( 2 ) : 201 - 204.
  • 8Wit JM, Clayton PE, Rogol AD, et al. Idiopathic short stature : Definition, epidemiology,and diagnostic evaluation [ J ]. Growth Horm IGF Res, 2008,18(2) :89 - 110.
  • 9Weedon MN, Lettre G,Freathy RM,et al. A common variant of HMGA2 is associated with adult and childhood height in the general population [J]. Nat Genet,2007,39(10) :1245 - 1250.
  • 10Lettre G. Genetic regulation of adult stature [ J ]. Curr Opin Pediatr, 2009,21 (4) :515 -522.

共引文献498

同被引文献31

  • 1Audrey D. Goddard,Patrick Dowd,Steven Chernausek,Mitchell Geffner,Joseph Gertner,Raymond Hintz,Nancy Hopwood,Selna Kaplan,Leslie Plotnick,Alan Rogol,Robert Rosenfield,Paul Saenger,Nellie Mauras,Richard Hershkopf,Morris Angulo,Kenneth Attie.Partial growth-hormone insensitivity: The role of growth-hormone receptor mutations in idiopathic short stature[J]. The Journal of Pediatrics . 1997 (1)
  • 2Niesler Beate,R?th Ralph,Wilke Steffi,Fujimura Frank,Fischer Christine,Rappold Gudrun.The novel human SHOX allelic variant database. Human Mutation . 2007
  • 3Rappold Gudrun,Blum Werner F,Shavrikova Elena P,Crowe Brenda J,Roeth Ralph,Quigley Charmian A,Ross Judith L,Niesler Beate.Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. Journal of Medicine . 2006
  • 4Liao,J,Xu,T.,Zheng, J.-X.,Lin,J.-M.,Cai, Q.-Y.,Yu, D.-B.,Peng, J.Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway. International journal of molecular medicine . 2013
  • 5Dobie R,Ahmed SF,Staines KA,et al.Increased linear bone by GH in the absence of SOCS2 is independent of IGF-1. Journal of Cellular Physiology . 2015
  • 6Gudrun A. Rappold,Maki Fukami,Beate Niesler,Simone Schiller,Walter Zumkeller,Markus Bettendorf,Udo Heinrich,Elpis Vlachopapadoupoulou,Thomas Reinehr,Kazumichi Onigata,Tsutomu Ogata.??Deletions of the Homeobox Gene SHOX (Short Stature Homeobox) Are an Important Cause of Growth Failure in Children with Short Stature(J)The Journal of Clinical Endocrinology & Metabolism . 2002 (3)
  • 7Patricia Park,Pinchas Cohen.??Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS)(J)Growth Hormone & IGF Research . 2005
  • 8Antonio Marchini,Gudrun Rappold,Katja U. Schneider.??SHOX at a glance: from gene to protein(J)Archives of Physiology and Biochemistry . 2007 (3)
  • 9CPBurren,DWanek,SMohan,PCohen,JGuevara‐Aguirre,RGRosenfeld.??Serum levels of insulin‐like growth factor binding proteins in Ecuadorean children with growth hormone insensitivity(J). 2008
  • 10Martin O.Savage,Christine P.Burren,Ron G.Rosenfeld.??The continuum of growth hormone–IGF‐I axis defects causing short stature: diagnostic and therapeutic challenges(J)Clinical Endocrinology . 2010 (6)

引证文献3

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部